Results 1 to 10 of about 2,528,262 (264)

A Novel Necroptosis-Associated lncRNA Signature Can Impact the Immune Status and Predict the Outcome of Breast Cancer

open access: yesJournal of Immunology Research, 2022
Breast cancer (BRCA) is one of the leading causes of death among women worldwide, and drug resistance often leads to a poor prognosis. Necroptosis is a type of programmed cell death (PCD) and exhibits regulatory effects on tumor progression, but few ...
Xin Zhang   +10 more
doaj   +1 more source

Endoscopic Nipple- or Skin-Sparing Mastectomy and Immediate Breast Reconstruction with Endoscopic Harvesting of the Latissimus Dorsi Flap: A Preliminary Experience of an Innovative Technique

open access: yesThe Breast Journal, 2022
Background. Endoscopic nipple- or skin-sparing mastectomy (E-N/SSM) and endoscopic latissimus dorsi muscle flap (E-LDMF) harvest have been operational difficulties over decades.
Yu Feng   +9 more
doaj   +1 more source

Identification of Crucial lncRNAs for Luminal A Breast Cancer through RNA Sequencing

open access: yesInternational Journal of Endocrinology, 2022
Background. The growing body of evidence indicates aberrant expression of long noncoding RNAs (lncRNAs) in breast cancer. Nevertheless, a few studies have focused on identifying key lncRNAs for patients with luminal A breast cancer.
Xinjian Jia   +8 more
doaj   +1 more source

High-Throughput Screening and Molecular Dynamics Simulation of Natural Products for the Identification of Anticancer Agents against MCM7 Protein

open access: yesApplied Bionics and Biomechanics, 2022
Minichromosome maintenance complex component 7 (MCM7) belongs to the minichromosome maintenance family that is necessary for the initiation of eukaryotic DNA replication.
Xin Zhang   +4 more
doaj   +1 more source

Changes in Breast Cancer Presentation during COVID-19: Experience in an Urban Academic Center

open access: yesInternational Journal of Breast Cancer, 2023
The COVID-19 pandemic strained healthcare systems worldwide, delaying breast cancer screening and surgery. In 2019, approximately 80% of breast cancers in the U.S.
Brian Diskin   +7 more
doaj   +1 more source

Development and Validation of a Novel PPAR Signaling Pathway-Related Predictive Model to Predict Prognosis in Breast Cancer

open access: yesJournal of Immunology Research, 2022
This study is aimed at exploring the potential mechanism of the PPAR signaling pathway in breast cancer (BRCA) and constructing a novel prognostic-related risk model.
Yingkun Xu   +9 more
doaj   +1 more source

CASP9 As a Prognostic Biomarker and Promising Drug Target Plays a Pivotal Role in Inflammatory Breast Cancer

open access: yesInternational Journal of Analytical Chemistry, 2022
Background. Inflammatory breast cancer (IBC) is one of the most rare and aggressive subtypes of primary breast cancer (BC). Our study aimed to explore hub genes related to the pathogenesis of IBC, which could be considered as novel molecular biomarkers ...
Mingdi Zhang   +4 more
doaj   +1 more source

MAPK/ERK-CBP-RFPL-3 Mediates Adipose-Derived Stem Cell-Induced Tumor Growth in Breast Cancer Cells by Activating Telomerase Reverse Transcriptase Expression

open access: yesStem Cells International, 2022
Adipose-derived stem cells (ASCs) improve the self-renewal and survival of fat grafts in breast reconstruction after oncology surgery. However, ASCs have also been found to enhance breast cancer growth, and its role in tumor proliferation remains largely
Wenjie Li   +11 more
doaj   +1 more source

“An Unusual Pattern of Metastasis” Metastatic Malignant Thymoma Presented with Breast Lump: A Case Report and Literature Review

open access: yesCase Reports in Surgery, 2023
Metastatic lesions to the breast from extramammary malignant neoplasms are rare and reported account for 0.5–6.6% of all breast malignancies. Distant metastasis of thymoma is even rarer, especially to extrathoracic regions.
Kah-Seng Khoo   +6 more
doaj   +1 more source

Comparative Efficacy of Neoadjuvant Endocrine Therapy, Neoadjuvant Chemotherapy, and Neoadjuvant Chemo-Endocrine Therapy in Estrogen Receptor–Positive Breast Cancer Patients: A Meta-Analysis

open access: yesThe Breast Journal
Neoadjuvant therapy before surgery offers varying benefits as a well-established treatment option for breast cancer. This study specifically evaluated the effectiveness of neoadjuvant endocrine therapy (NET), neoadjuvant chemotherapy (NCT), and ...
Yi Yuan   +5 more
doaj   +1 more source

Home - About - Disclaimer - Privacy